"Botanix’s cash reserve is expected to be more than sufficient...

"Botanix’s cash reserve is expected to be more than sufficient to fund the planned BTX 1801 (antimicrobial) and BTX
1702 (rosacea) programs and support Company costs over the coming 24 months.."

"increasing the potential to license or partner its development assets across both platforms"; - is this a subtle hint from Mr V & the gang???

Not many companies out there ATM that can sustain themselves never mind for the next 2 years...MASSIVE TICKS

Ph3 BTX1503 FDA meeting still planned and going ahead as scheduled....TICK TICK..could still be the company maker.. ???
BTX1801 - still planned and main focus of the company now - TICK TICK - also not a trial that we need to wait FOREVER for results - need success to recover our $$'s invested here..main focus is now here - could be the company maker we are all sooo patiently waiting for..
BTX1204 - did not meet expectations.. well that's what trials are for.. not every trial will be a success.. Dammit.. oh well.. good not to waste $$ here..
BTX1702/1308 - on hold/suspended due to current climate etc...

So we still have a few very possible valuable irons in the fire.. These boys don't build billion dollar companies for nothing.. trial and error till success.. Will start to slowly average down in BOT so when she turns happy days..either gonna make me very rich or start all over.. roll the dice and let's see.... GLTAH..